Literature DB >> 24700371

CDK2 and CDK4 play important roles in promoting the proliferation of SKOV3 ovarian carcinoma cells induced by tumor-associated macrophages.

Yang Yang1, Biao Ma2, Ling Li3, Ye Jin1, Wei Ben1, Dandan Zhang1, Keping Jiang1, Shujun Feng1, Lu Huang1, Jianhua Zheng1.   

Abstract

A large quantity of M2-polarized tumor-associated macrophages (TAMs) is present in the tissue, ascitic fluid and peritoneum of ovarian cancer patients. A thorough understanding of the roles of M2-TAM in the development of ovarian cancer may provide new insight into the treatment of this disease. The rapid advancement of omics techniques presents a great challenge to biologists to extract meaningful biological information from vast pools of data. In the present study, using microarray method, we identified 996 genes in SKOV3 ovarian carcinoma cells that underwent expression level changes under the influence of TAMs. Subsequently, based on the protein-protein interactions network and the differentially expressed genes, a network showing the influence of TAMs on SKOV3 cells was constructed. The resulting network was analyzed with CFinder software and four modules were found; these modules were further analyzed using David software to perform functional annotations. It was found that module I was mainly related to tumorigenesis and cell cycle. Hence, 31 genes in module I were analyzed with Cytoscape software to generate a gene-function network, which revealed that four gene proteins (E2F1, RB1, CDK2 and CDK4) were functional. Based on literature review, we postulated that CDK2 and CDK4 were key players in the network. In the subsequent molecular experiments, western blot analysis and kinase activity detection demonstrated that TAMs can significantly boost the expression levels and activities of CDK2 and CDK4 in SKOV3 cells. With 3H-TdR incorporation and flow cytometry assay, the proliferation and cell cycle distribution of SKOV3 cells were detected in the absence or presence of CDK2 and CDK4 inhibitors and the results confirmed that the two kinases played a key role in TAM cells enhancing SKOV3 cell proliferation by promoting G0/G1 to S transition. In the present study, we identified the specific changes in the gene expression profile of SKOV3 cells under the influence of TAMs and explored a method for analyzing the gene expression profile data. The results may aid in the design of subsequent molecular experiments.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24700371     DOI: 10.3892/or.2014.3127

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  TGF-β Regulates Survivin to Affect Cell Cycle and the Expression of EGFR and MMP9 in Glioblastoma.

Authors:  Wenliang Chen; Xiao Zhong; Yi Wei; Yun Liu; Quan Yi; Genshui Zhang; Lishan He; Fajiang Chen; Yingping Liu; Jiandong Luo
Journal:  Mol Neurobiol       Date:  2015-02-17       Impact factor: 5.590

2.  Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss.

Authors:  Yan Gao; Jacson Shen; Edwin Choy; Henry Mankin; Francis Hornicek; Zhenfeng Duan
Journal:  Cell Oncol (Dordr)       Date:  2017-02-27       Impact factor: 6.730

3.  SDF-1/CXCR4 Axis Regulates Cell Cycle Progression and Epithelial-Mesenchymal Transition via Up-regulation of Survivin in Glioblastoma.

Authors:  Anyan Liao; Ranran Shi; Yuliang Jiang; Suqing Tian; Panpan Li; Fuxi Song; Yalan Qu; Jinna Li; Haiqin Yun; Xiangshan Yang
Journal:  Mol Neurobiol       Date:  2014-11-25       Impact factor: 5.590

4.  [Role of miR-206/CDK4 in modulating the growth and chemotlerapy sensitivity of ovarian cancer cells].

Authors:  Chen Ling; Shu Liu; Yong Wang; Feng-Chun Zhang; Ying DU
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

5.  The expression of CDK1 is associated with proliferation and can be a prognostic factor in epithelial ovarian cancer.

Authors:  Qinghua Xi; Menghui Huang; Yingying Wang; Jianxin Zhong; Rong Liu; Guiqin Xu; Lifei Jiang; Juan Wang; Zheng Fang; Shuyun Yang
Journal:  Tumour Biol       Date:  2015-04-25

6.  Non-canonical roles of PFKFB3 in regulation of cell cycle through binding to CDK4.

Authors:  Wenzhi Jia; Xiaoping Zhao; Li Zhao; Hui Yan; Jiajin Li; Hao Yang; Gang Huang; Jianjun Liu
Journal:  Oncogene       Date:  2018-01-16       Impact factor: 9.867

7.  Enrichment Analysis Identifies Functional MicroRNA-Disease Associations in Humans.

Authors:  Dandan Yuan; Xiaomeng Cui; Yang Wang; Yilei Zhao; Huiying Li; Suangjiu Hu; Xiaodan Chu; Yan Li; Qiang Li; Qian Liu; Wenliang Zhu
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

8.  siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease.

Authors:  Ilaria Russo; Albino Carrizzo; Sabrina Bochicchio; Ornella Piazza; Gaetano Lamberti; Anna Angela Barba; Carmine Vecchione; Pio Zeppa; Paola Iovino; Cristina Bucci; Antonella Santonicola; Carolina Ciacci
Journal:  Transl Med UniSa       Date:  2018-03-31

9.  siRNA Delivery for Control of Cyclin D1 and E2F1 Expression in Crohn's Disease.

Authors:  Ilaria Russo; Albino Carrizzo; Sabrina Bochicchio; Ornella Piazza; Gaetano Lamberti; Anna Angela Barba; Carmine Vecchione; Pio Zeppa; Paola Iovino; Cristina Bucci; Antonella Santonicola; Carolina Ciacci
Journal:  Transl Med UniSa       Date:  2018-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.